Related Experiment Video
Updated: Oct 19, 2025
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.0K
Targeting pancreatic ductal adenocarcinoma: New therapeutic options for the ongoing battle
Pratibha Malhotra1, Ranjith Palanisamy1, Marco Falasca1
1Metabolic Signalling Group, Curtin Medical School, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, 6102, Australia.
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|September 18, 2021
Abstract
No abstract available in PubMed .
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
143
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
143
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K